Mannitol - Potential Role in Hemodialysis Initiation for Reduction of Intra-dialytic Hypotension



Status:Completed
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:2/1/2019
Start Date:May 2012
End Date:December 2018

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Pilot Study of Intravenous Mannitol During Hemodialysis Initiation to Reduce the Occurrence of Intra-dialytic Hypotension.

Kidney failure can result from a variety of conditions and can be temporary or permanent.
Hemodialysis is available as a replacement treatment to perform the work that the kidneys
normally do. However, the dialysis procedure can be associated with rapid changes in the
composition of the blood - this may lead to changes in blood pressure and in turn reduced
blood supply to important parts of the body. We aim to investigate if giving a medicine
(called mannitol) during dialysis may be able to reduce the frequency of these low blood
pressure events.


Inclusion Criteria:

- Renal failure requiring intermittent hemodialysis initiation; adult patients aged over
18 years; written informed consent

Exclusion Criteria:

- Hyponatremia <130 mmol/L; acute myocardial infarction or stroke in previous 7 days;
cardiac transplant; ventricular arrhythmia; unstable angina; use of
pressors/midodrine; enrollment in conflicting research study; institutionalized
individuals; pregnancy; prisoners; documented allergy to mannitol
We found this trial at
1
site
Brigham and Women's Hosp
75 Francis street
Boston, Massachusetts 02115
(617) 732-5500
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
?
mi
from
Boston, MA
Click here to add this to my saved trials